Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Experience with Rayner T-flex aspheric toric intraocular lens

Poster Details

First Author: V.Velika CZECH REPUBLIC

Co Author(s):    P. Rozsival              

Abstract Details



Purpose:

To assess astigmatic reduction of Rayner T-flex toric intraocular lenses (IOL) in a series of cataract and refractive surgery patients with corneal astigmatism.

Setting:

Charles University, Dept. Ophthalmology, Hradec Králové, Czech Republic

Methods:

This retrospective study includes 18 eyes, 11 patients, with mean pre-operative corneal astigmatism -1,69±1,14 (-0,82D to -5,72D)D in which Rayner T-flex toric IOL was implantated after phacoemulsification. Mean IOL sphere power was 18,4±7,21 (8,0 - 29,0)D. Uncorrected distance visual acuity (UDVA), best corrected distance visual acuity (BCDVA), residual refractive sphere and residual refractive cylinder were measured one month after surgery.

Results:

Mean UDVA 1 months after surgery was 0.94±0.34D and mean BCDVA was 1,0±0.20D. Target refraction in 2 high myopic eyes was -2D. Mean refractive postoperative sphere was -0,15±0.86D and mean refractive postoperative cylinder was -0,06±0.21D. Rayner® T-flex &trade623T PRM +11,5Dsf /+8,5Dcyl was implanted in a forty year old patient who underwent cataract surgery after penetrating keratoplasty for keratoconus: UDVA = 0,8, SE=-0,3D was achieved 1 month after surgery.

Conclusions:

Rayner T-flex Rayner T-flex aspheric toric IOL implantation is an effective and reliable option to correct corneal astigmatism in cataract and refractive surgery. FINANCIAL INTEREST: NONE

Back to Poster listing